Induction of tissue factor expression and release as microparticles in ECV304 cell line by Chlamydia pneumoniae infection

Atherosclerosis

Volumn 190, Issue 2, 2007, Pages 343-351

  Ettelaie, Camille ^a   Collier, Mary E W ^a   James, Nicola J ^b   Li, Chao ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Chlamydia pneumoniae; Endothelium; Microparticles; NF B; Tissue factor

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN THROMBOPLASTIN HYBRID PROTEIN; HYBRID PROTEIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PYRROLIDINEDITHIOCARBAMATE AMMONIUM; THROMBOPLASTIN; UNCLASSIFIED DRUG;

ARTICLE; ATHEROGENESIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; KINETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; VASCULAR DISEASE;

BASE SEQUENCE; CELL LINE; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; DNA PRIMERS; ENDOTHELIUM, VASCULAR; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THROMBOPLASTIN;

EID: 33846049542     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.04.005     Document Type: Article

References (32)

1. Dugan J.P., Feuge R.R., and Burgess D.S. Review of evidence for a connection between Chlamydia pneumoniae and atherosclerotic disease. Clin Ther 24 (2002) 719-735
2. Kwon T.W., Kim do K., Ye J.S., et al. Detection of enterovirus, cytomegalovirus, and Chlamydia pneumoniae in atheromas. J Microbiol 42 (2004) 299-304
3. Sessa R., Di Pietro M., Schiavoni G., et al. Detection of Chlamydia pneumoniae in atherosclerotic coronary arteries. Int J Immunopathol Pharmacol 17 (2004) 301-306
4. Kolia M., and Fong I.W. Chlamydia pneumoniae and cardiovascular disease. Curr Infect Dis Rep 4 (2002) 35-43
5. Belland R.J., Ouellette S.P., Gieffers J., and Byrne G.I. Chlamydia pneumoniae and atherosclerosis. Cell Microbiol 6 (2004) 117-127
6. Shi Y., and Tokunaga O. Chlamydia pneumoniae (C. pneumoniae) infection upregulates atherosclerosis-related gene expression in human umbilical vein endothelial cells (HUVECs). Atherosclerosis 177 (2004) 245-253
7. Spronk H.M., van der Voort D., and Ten Cate H. Blood coagulation and the risk of atherothrombosis: a complex relationship. Thromb J 2 (2004) 12
8. Ott I., Fischer E.G., Miyagi Y., Mueller B.M., and Ruf W. A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280. J Cell Biol 140 (1998) 1241-1253
9. Abe K., Shoji M., Chen J., et al. Regulation of vascular endothelial growth factor production and angiogenesis by cytoplasmic tail of tissue factor. Proc Natl Acad Sci USA 96 (1999) 8663-8668
10. Ollivier V., Chabbat J., Herbert J.M., Hakim J., and de Prost D. Vascular endothelial growth factor production by fibroblasts in response to factor VIIa binding to tissue factor involves thrombin and factor Xa. Arterioscler Thromb Vasc Biol 20 (2000) 1374-1381
11. Sato Y., Kataoka H., Asada Y., et al. Overexpression of tissue factor pathway inhibitor in aortic smooth muscle cells inhibits cell migration induced by tissue factor/factor VIIa complex. Thromb Res 94 (1999) 401-406
12. Jude B., Zawadzki C., Susen S., and Corseaux D. Relevance of tissue factor in cardiovascular disease. Arch Mal Coeur Vaiss 98 (2005) 667-671
13. Diamant M., Tushuizan M.E., Sturk A., and Nieuwland R. Cellular microparticles: new players in the field of vascular disease?. Eur J Clin Invest 34 (2004) 392-401
14. Mallat Z., Hugel B., Ohan J., Leseche G., Freyssinet J.M., and Tedgui A. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 99 (1999) 348-353
15. Morel O., Toti F., Hugel B., and Freyssinet J.M. Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr Opin Hematol 11 (2004) 156-164
16. Dechend R., Maass M., Gieffers J., et al. Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression. Circulation 100 (1999) 1369-1373
17. Fryer R.H., Schwobe E.P., Woods M.L., and Rodgers G.M. Chlamydia species infect human vascular endothelial cells and induce procoagulant activity. J Invest Med 45 (1997) 168-174
18. Bea F., Puolakkainen M.H., McMillen T., et al. Chlamydia pneumoniae induces tissue factor expression in mouse macrophages via activation of egr-1 and the MEK-ERK1/2 pathway. Circ Res 92 (2003) 394-401
19. Baer J.T., Du Laney T.V., Wyrick P.B., et al. Nuclear factor-kappaB activation in endothelium by Chlamydia pneumoniae without active infection. J Infect Dis 188 (2003) 1094-1097
20. Pradier A., James N.J., Bruckdorfer K.R., and Ettelaie C. The influence of tissue factor (CD142) on endothelial cell apoptosis and proliferation. J Thromb Haemost Suppl. 1 (2003) 165
21. Suda K., Rothen-Rutishauser B., Gunthert M., and Wunderli-Allenspach H. Phenotypic characterisation of human umbilical vein endothelial (ECV304) and urinary carcinoma (T24) cells: endothelial versus epithelial features. In Vitro Cell Dev Biol Anim 37 (2001) 505-514
22. Chirgwin K., Roblin P.M., and Hammerschlag M.R. In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp Strain TWAR). Antimicrob Agents Chemother 33 (1989) 1634-1635
23. Berger M., Schroder B., Daeschlein G., Schneider W., Busjahn A., Buchwalow I., Luft F.C., and Haller H. Chlamydia pneumoniae DNA in non-coronary atherosclerotic plaques and circulating leukocytes. J Lab Clin Med 136 (2000) 194-200
24. Schreck R., Meier B., Mannel D.N., Droge W., and Baeuerle P.A. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med 175 (1992) 1181-1194
25. Bustin S.A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 25 (2000) 169-193
26. Yuan Z.-M., Huang Y., Ishiko T., et al. Role for p300 in stabilization of p53 in the response to DNA damage. J Biol Chem 274 (1999) 1883-1886
27. Tetsuka T., Uranishi H., Imai H., et al. Inhibition of nuclear factor-κB-mediated transcription by association with the amino-terminal enhancer of split, a Groucho-related protein lacking WD40 repeats. J Biol Chem 275 (2000) 4383-4390
28. Aras O., Shet A., Bach R.R., et al. Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. Blood 103 (2004) 4545-4553
29. Kol A., and Libby P. The mechanisms by which infectious agents may contribute to atherosclerosis and its clinical manifestations. Trends Cardiovasc Med 8 (1998) 191-199
30. Mackman N., Brand K., and Edgington T.S. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites. J Exp Med 174 (1991) 1517-1526
31. Del Conde I., Shrimpton C.N., Thiagarajan P., and López J.A. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 106 (2005) 1604-1611
32. Biro E., Sturk-Maquelin K.N., Vogel G.M., et al. Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb Haemost 1 (2003) 2561-2568